Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control.

Juraj StanikA DankovcikovaL BarakM SkopkovaM PalkoJ DivinecI KlimesD Gasperikova

Published in: Diabetic medicine : a journal of the British Diabetic Association (2018)

Our data show that sulfonylurea monotherapy might be preferable to insulin in people with permanent neonatal diabetes mellitus sensitive to sulfonylurea even when HbA1c is above target.

Keyphrases

type diabetes
glycemic control
randomized controlled trial
big data
clinical trial
combination therapy
machine learning
weight loss
metabolic syndrome
insulin resistance
mesenchymal stem cells
skeletal muscle
cell therapy
smoking cessation